Anacor Pharmaceuticals reports plans to price public sale of shares

Manager Cowen raises funds for research, development, working capital

By Devika Patel

Knoxville, Tenn., Oct. 17 - Anacor Pharmaceuticals, Inc. will price a public offering of common stock with a 30-day greenshoe option, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Cowen and Co., LLC is the manager.

Proceeds will be used for research and development activities, working capital and general corporate purposes.

The pharmaceutical company is based in Palo Alto, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.